Diets
intermittent fasting is noninferior to continuous calorie restriction for glycemic control
In plain terms: Is 5:2-style intermittent fasting as good as everyday calorie-cutting for HbA1c and weight in type 2 diabetes?
Part of: 🥗 intermittent fasting
Yes — head-to-head randomized non-inferiority trials show 5:2/intermittent energy restriction matches daily calorie restriction for HbA1c and weight loss, so it is a reasonable equivalent option, not a superior one.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
Head-to-head randomised trials and their meta-analyses show intermittent fasting matching continuous calorie restriction for HbA1c and weight in type 2 diabetes and prediabetes, with no significant between-group difference on glucose indices. This is a non-inferiority finding rather than evidence of superiority, and the underlying trial base is small and short.
The evidence (14)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Li H, Li T 2026 · Front Nutr | meta-analysis | supports | moderate | SR/MA 9 RCTs (n=894) IF vs CER in MASLD: no significant between-group difference on glucose indices (IF favored only on weight/BMI/LDL). Consistent with glycemic non-inferiority; scope=MASLD not diagnosed T2D. |
| Khalafi M, Habibi Maleki A, Symonds ME, Rosenkranz SK, Rohani H, Ehsanifar M 2024 · Diabetes Obes Metab | meta-analysis | mixed | moderate | Meta-analysis in prediabetes/T2D found intermittent fasting improved body composition/cardiometabolic markers similarly to calorie restriction, not clearly superior. |
| Lakhani HA, Biswas D, Kuruvila M, Chava MS, Raj K, Varghese JT, Swathi NL 2025 · Prim Care Diabetes | observational | mixed | low | Review notes IF gives strong short-term HbA1c and weight benefits comparable to continuous restriction but with weaker long-term durability and adherence data. |
| Vitale R, Kim Y 2020 · Metab Syndr Relat Disord | meta-analysis | mixed | low | Systematic review of RCTs found intermittent fasting improved glycemic indices/body composition in T2D but evidence base was small and heterogeneous. |
| Borgundvaag E, Mak J, Kramer CK 2021 · J Clin Endocrinol Metab | meta-analysis | supports | moderate | Meta-analysis of interventional studies found intermittent fasting reduced HbA1c and weight in T2D comparably to standard energy restriction. |
| Semnani-Azad Z, Khan TA, Chiavaroli L, Chen V, Bhatt HA, Chen A, Chiang N, Oguntala J, Kabisch S, Lau DC, Wharton S, Sharma AM, Harris L, Leiter LA, Hill JO, Hu FB, Lean ME, Kahleová H, Rahelic D, Salas-Salvadó J, Kendall CW, Sievenpiper JL 2025 · BMJ | meta-analysis | supports | high | Network meta-analysis of RCTs: intermittent fasting produced small added weight/cardiometabolic benefit vs continuous energy restriction but effects were modest and largely comparable. ⚠️ correction-on-file (Crossref) - kept, corrigendum not retraction |
| Wang X, Li Q, Liu Y, Jiang H, Chen W 2021 · Diabetes Res Clin Pract | meta-analysis | supports | moderate | Meta-analysis of RCTs found IF and continuous energy-restricted diets produced similar glycemic control and weight loss in type 2 diabetes / metabolic syndrome. |
| Carter S, Clifton PM, Keogh JB 2018 · JAMA Netw Open | RCT | supports | high | In a 12-month randomized non-inferiority trial in type 2 diabetes, two-day-per-week intermittent energy restriction was non-inferior to continuous restriction for HbA1c and weight change. ↩ SUPERSEDED — pooled in the review above, counted once |
| Carter S, Clifton PM, Keogh JB 2019 · Diabetes Res Clin Pract | RCT | supports | moderate | 24-month follow-up confirmed intermittent and continuous energy restriction produced comparable long-term glycemic control, with adherence declining in both arms. |
| Dietvorst CAW, Geurts KAM, Lodari O, Boon MR, van Rossum EFC, Visser WJ, Berk KA 2026 · Clin Nutr ESPEN | RCT | mixed | moderate | 3-month RCT found intermittent and continuous calorie restriction produced similar body-composition and resting-energy-expenditure changes in T2D. |
| Schroor MM, Joris PJ, Plat J, Mensink RP 2024 · Adv Nutr | meta-analysis | supports | high | Meta-analysis of 28 trials found intermittent energy restriction and continuous restriction yielded comparable body-weight and cardiometabolic outcomes. |
| Al Qudah J, Beni ND, Ibrahim N, Khader S, Dempsey L, Butler AE 2026 · Front Nutr | meta-analysis | tested-null | low | Meta-analysis found intermittent fasting improved HbA1c and weight in oral-therapy-treated but not insulin-treated T2D patients. |
| Carter S, Clifton PM, Keogh JB 2016 · Diabetes Res Clin Pract | RCT | supports | moderate | Pragmatic pilot RCT found 2-day intermittent (5:2-style) restriction produced HbA1c and weight changes equivalent to continuous restriction in T2D. ↩ SUPERSEDED — pooled in the review above, counted once |
| Abdollahpour N, Seifi N, Nosrati M, Esmaily H, Shahri AMM, Ferns GA, Alinezhad-Namaghi M, Ghayour-Mobarhan M 2025 · Scientific reports | observational | supports | low | Cohort n=82, 5:2 vs daily CR in overweight/obese: glycemic markers similar between groups (IF differed only on BP/TG/CVD-risk). Underpowered but consistent with non-inferiority. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.